Smartleaf Asset Management »

Agios Pharmaceuticals shares owned by Smartleaf Asset Management

Quarter-by-quarter ownership of Agios Pharmaceuticals (AGIO) shares owned by Smartleaf Asset Management from 13F filings

Historical chart of Smartleaf Asset Management investment in Agios Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Agios Pharmaceuticals held by Smartleaf Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Agios Pharmaceuticals by Smartleaf Asset Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $18k 393 45.61
2024-06-30 $3.8k 86 43.60

More positions owned by Smartleaf Asset Management

Apple (AAPL)
Microsoft Corporation (MSFT)
Vanguard World Mega Cap Val Etf (MGV)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Meta Platforms Cl A (META)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Wisdomtree Tr Us Quality Grow (QGRW)
Wisdomtree Tr Yield Enhancd Us (AGGY)
Alphabet Cap Stk Cl A (GOOGL)
Wisdomtree Tr Us Qtly Div Grt (DGRW)
Vanguard Intl Equity Index F Tt Wrld St Etf (VT)
Dimensional Etf Trust Us Core Equity 1 (DCOR)
Dimensional Etf Trust Us Core Equity 2 (DFAC)
Ishares Tr Core S&p500 Etf (IVV)

View all positions for Smartleaf Asset Management

Top funds holding Agios Pharmaceuticals

BlackRock
Bellevue Group
T. Rowe Price Associates
Erste Asset Management GmbH
Jpmorgan Chase & Co
Dimensional Fund Advisors
Geode Capital Management
Marshall Wace
BVF
Frazier Life Sciences Management
Bnp Paribas Investment Partners
Arrowpoint Asset Management
Fisher Investments
Vestal Point Capital
Deutsche Bank Aktiengesellschaft

View all funds holding Agios Pharmaceuticals